15:52:49 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandDanmark
ListaSpotlight DK
SektorHälsovård
IndustriMedicinteknik
Curasight är verksamma inom läkemedelsbranschen. Bolaget är specialiserade inom utveckling av teknologiska produkter. Produktportföljen är bred och fokuserar i stor grad utveckling av produkter inom området Positron Emissions Tomography (PET). Verksamheten drivs med störst närvaro inom Skandinavien. Curasight har sitt huvudkontor i Köpenhamn.

Kalender

2023-11-24 Kvartalsrapport 2023-Q3
2023-08-24 Kvartalsrapport 2023-Q2
2023-05-25 Kvartalsrapport 2023-Q1
2023-03-30 Årsstämma 2023
2023-02-23 Bokslutskommuniké 2022
2022-11-24 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-24 Kvartalsrapport 2022-Q1
2022-04-27 Årsstämma 2022
2022-03-25 Ordinarie utdelning CURAS 0.00 DKK
2022-02-24 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-24 Kvartalsrapport 2021-Q2
2021-06-01 Extra Bolagsstämma 2021
2021-05-20 Kvartalsrapport 2021-Q1
2021-03-26 Ordinarie utdelning CURAS 0.00 DKK
2021-03-25 Årsstämma 2021
2021-02-24 Bokslutskommuniké 2020
2020-11-30 Kvartalsrapport 2020-Q3
2022-04-27 14:46:37

Curasight A/S, CVR no. 35 24 93 89 ("Curasight" or the "Company") held its Annual General Meeting on 27 April 2022 at 10:00 (CET) at the Company's premises, Ole Maaløes Vej 3, room M7, DK-2200 Copenhagen N, Denmark.

Today, Curasight A/S ("Curasight" or the "Company") adopted the following resolutions at its Annual General Meeting:

Presentation and approval of the annual report

The General Meeting adopted the annual report for the financial year 2021.

Appropriation of profit or covering of loss as recorded in the adopted annual report

The General Meeting adopted the Board of Directors' proposal to carry forward the result for 2021 to the next year in accordance with the adopted annual report for 2021.

Election of members to the Board of Directors

The General Meeting re-elected the following members of the Board of Directors:
  • Per Falholt
  • Lars Trolle
  • Andreas Kjær
  • Charlotte Vedel
  • Kirsten Aarup Drejer
  • Ulrich Krasilnikoff

Election of auditor

The General Meeting re-elected PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab as auditor of the Company.

Amendment of the Articles of Association

The General Meeting adopted a proposal to amend the Articles of Association in accordance with the updated version of the Articles of Association attached to the notice convening the Annual General Meeting.

Authorisations to increase the share capital

The General Meeting adopted a resolution to authorise the Board of Directors to increase the share capital with and without pre-emption rights until 26 April 2027.

Incentive Programs (Authorisations to issue warrants)

The General Meeting adopted authorisations to the Board of Directors to issue warrants for the purpose of establishing incentive programs for the Board of Directors, the Executive Management and employees of the Company.

Authorisation to the chairman of the meeting

The General Meeting adopted a resolution to authorise the chairman of the meeting to apply for registration of the resolutions passed and to make certain amendments, if necessary.

*****

At the board meeting held immediately after the Annual General Meeting, Per Falholt was re-elected chairman and Lars Trolle vice-chairman of the Board of Directors.